Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer.
Greidanus
J
J
Department of Internal Medicine, University Hospital, Groningen, The Netherlands.
Willemse
P H
PH
Sleijfer
D T
DT
Mulder
N H
NH
Verschueren
R C
RC
Nieweg
R
R
de Vries
E G
EG
D000328:Adult; D000368:Aged; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D015251:Epirubicin; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy*
D015251:Epirubicin; D004317:Doxorubicin